UCB and Cradle Expand AI-Powered Antibody Discovery
Brussels, Belgium, and Amsterdam, Netherlands, November 4, 2026 UCB, a global biopharmaceutical company, has announced a strategic collaboration with...
antibody engineering
Advertisement
Castle Biosciences Study Supports Molecular Guidance in AD
Friendswood, Texas, U.S., September 24, 2026 Castle Biosciences, Inc. has announced findings from a new study highlighting the potential...
Henlius Partners With Amberstone on Next-Gen TCEs
Shanghai, China, September 24, 2026 Henlius has announced a strategic partnership with Amberstone Biosciences to discover and develop next-generation...
Firefly Bio Acquisition Strengthens J&J Cancer Portfolio
MONTEREY, Calif., July 29, 2026 Johnson & Johnson has completed its $1 billion acquisition of Firefly Bio, Inc., significantly...
Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies
SAN DIEGO, Calif. and BOSTON, Mass., June 20, 2026 Voro Therapeutics and Alloy Therapeutics have announced a strategic research...
Advertisements
Protillion Biosciences Partners With Merck on AI Drug Discovery
CARLSBAD, Calif., June 16, 2026 Protillion Biosciences has announced a significant multi-target drug discovery collaboration and license agreement with...
Inhibrx Reports Progress for INBRX-106 in HNSCC Trial
SAN DIEGO – May 8, 2026 Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on oncology and rare diseases,...
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
Nona Biosciences Names Chief AI Officer to Drive A³ Drug Discovery
Cambridge, MA – December 3, 2025: Nona Biosciences has appointed Dr. Hongjiang Miao as its first Chief AI Officer,...
Advertisement
